ALDH2 and coronary artery disorder: In contrast, the CAD group showed a significant increase in age, the proportion of the ALDH2 genotype (GA + AA/GG), the history of lipid‐lowering drug use, and the duration of lipid‐lowering drug treatment compared with the non‐CAD group (p < 0.05), as detailed in Table 2.